ScreenerHero

STX Shield Therapeutics plc

LSE · GB · Healthcare · Drug Manufacturers - Specialty & Generic · shieldtherapeutics.com
5.950GBp0.00%Mkt Cap: 69.47M $P/E: —

Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Fera…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap69.47M USD
Enterprise Value87.19M USD
Revenue (TTM)63.72M USD
Gross Profit25.04M USD
Net Income (TTM)-19.19M USD
Revenue/Share0.06 GBp
Last Price5.950 GBp
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees61
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)7.93
PEG—
EV/EBITDA-18.11
EV/Revenue1.37
P/S1.09
P/B-4.92
EPS (TTM)-0.01
EPS (Forward)0.01
52W Range
3.70026% of range12.50
52W High12.50 GBp
52W Low3.700 GBp
Profitability
Gross Margin46.36%
Oper. Margin0.69%
EBITDA Margin-7.56%
Profit Margin-35.52%
ROE117.10%
ROA-27.07%
Growth
Revenue Growth41.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.67M USD
CapEx (TTM)326.09K USD
FCF Margin-5.48%
FCF Yield-5.03%
Net Debt18.00M USD
Net Debt/EBITDA-3.74
Balance Sheet
Debt/Equity-2.00
Current Ratio0.75
Quick Ratio0.55
Book Value/Sh-0.01 GBp
Cash/Share0.0080 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 GBp
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)16.67 GBp
Upside (mean)+180.1%
Target Range12.00 GBp – 23.00 GBp
12.00+180.1% to mean23.00
# Analysts3
Ownership
Shares Out.1.07B
Float413.37M
Insiders61.51%
Institutions3.32%
Technical
SMA 504.909 (+21.2%)
SMA 2007.441 (-20.0%)
Beta1.77
S&P 52W Chg14.58%
Avg Vol (30d)2.86M
Avg Vol (10d)2.53M
Technical Indicators
RSI (14)63.5
MACD0.2067
MACD Signal0.0641
MACD Hist.+0.1426
BB Upper6.279 GBp
BB Middle5.171 GBp
BB Lower4.063 GBp
BB Width42.86%
ATR (14)0.3920 GBp
Vol Ratio (20d)0.61x